New York drug laws have evolved significantly in recent years, particularly following the Marihuana Regulation and Taxation Act (MRTA) of 2021 and expanded diversion programs for low-level offenses. However, the framework for serious drug charges remains aggressive, and federal prosecutions — which carry their own mandatory minimum sentences under statutes such as 21 U.S.C. §841 — are a real risk in complex distribution and trafficking cases, especially those involving fentanyl or large-scale networks.

Criminal possession of a controlled substance is tiered across seven degrees under the New York Penal Law, with severity increasing based on the type of substance and the quantity involved. At the misdemeanor level, possession of small amounts can still result in jail time, probation, and a permanent record. At the felony level — particularly for possession with intent to sell or for operating as part of a larger distribution network — the consequences can include years or decades in state or federal prison.

Beyond the criminal penalties, drug convictions carry significant collateral consequences. For non-citizens, many drug offenses trigger mandatory immigration consequences, including deportation and bars to future legal status. For business professionals, a drug conviction can mean the loss of professional licenses, security clearances, or the ability to serve as a corporate officer.

Our defense strategy in drug cases examines every step of the investigation that led to the charge: the basis for any traffic stop, the legality of a search, the chain of custody for physical evidence, and whether any informant testimony is reliable. Fourth Amendment violations — unlawful searches and seizures — remain one of the most effective grounds for suppressing evidence and undermining the prosecution’s case.

Where appropriate, we also advocate for alternative sentencing programs, including drug court and treatment-based diversion, which can resolve a case without a traditional conviction on your record.